Walter J. Koroshetz, MD, Director, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)

NIH is the taxpayers’ investment in biomedical research and clinician-scientists are critical in making good on this investment. NINDS and other Institutes have special grant mechanisms to train clinician scientists at various career stages and there are many research paths to consider. These including developing a laboratory effort, a clinical research effort or joining a research team. Modern Neurology research is a team science effort which opens research opportunities for almost all Neurologists. Neurotechnologies are advancing rapidly and might be attractive to pursue to bring new tools to solving important neurological problems. There is also an effort being launched to test interventions to advance health equity and special funding at NIH for pain and dementia research that one might consider.

Frances E. Jensen, MD, FACP, FANA, Arthur Knight Asbury, Professor in Neurology; Chair, Neurology Department, University of Pennsylvania School of Medicine

Craig D. Blackstone, MD, PhD, FANA, RCR 2023 Co-Director; Professor of Neurology, Harvard Medical School; Chief, Movement Disorders Division, Massachusetts General Hospital

Jacqueline A. French, MD, FANA, Professor of Neurology; Director, Translational Research and Clinical Trials in Epilepsy, New York University Grossman School of Medicine

Translational research stretches from “T1” (Translation to Humans: developing treatments and interventions), which addresses the transition from pre-clinical to clinical applications, through T2 ( Translation to patients: testing the efficacy and effectiveness of these treatments and interventions.), T3 (Translation to practice: dissemination and implementation research for system-wide change) and T4: (Translation to communities, population level outcomes). During T2 new interventions will be tested under controlled environments, usually using randomized controlled trials to form the basis for FDA approval. This evidence will then be translated into clinical guidelines. This talk will address the potential disparity between what is learned from experiments in a controlled environment vs what must be learned in other ways, and how that may ultimately impact how we use these interventions in the clinic.

Brian L. Edlow, MD, Neurocritical Care Faculty, Massachusetts General Hospital; Director, Laboratory for NeuroImaging of Coma and Consciousness (NICC); Associate Director, Center for Neurotechnology and Neurorecovery (CNTR); Affiliated Faculty, Athinoula A. Martinos Center for Biomedical Imaging; Associate Professor of Neurology, Harvard Medical School

Life and Investigation in Industry – NO CME CREDITS OFFERED

Michael Panzara, MD, MPH, Chief Medical Officer, Neurvata Neurosciences

The past 20 years have seen unprecedented innovation and focus on developing therapeutics for neurological disorders. This has created enormous opportunities for neurologists interested in drug development and commercialization across the entire landscape from biotech start-ups to large pharmaceutical companies. A case study of one potential path will be presented along with a review of the potential roles for neurologists in industry.

Sadhana Chitale, PhD, MBA, Senior Director of Life Sciences/ Technology, New York University Grossman School of Medicine; Board Member, Association of University Technology Managers (AUTM)

This session will explore the critical role of technology commercialization in academia and its impact on the innovation ecosystem. The session will delve into the challenges associated with bridging the gap between academia and industry, including intellectual property protection, licensing, funding, and entrepreneurship. This will also cover strategies for successful technology transfer, such as identifying market opportunities, building partnerships, and creating a culture of innovation. Ultimately, this presentation will showcase the potential of technology commercialization to drive economic growth and societal impact, while highlighting the importance of collaboration between academia, industry, and government.

Anthony S. Kim, MD, FANA, MAS, Associate Professor of Neurology, UCSF Weill Institute for Neurosciences; Medical Director, UCSF Stroke Center; Director, Biostatistics & Study Design, CTSI, University of California, San Francisco

This session will describe the mission of Clinical and Translational Science Awards (CTSAs), including training and education/career development resources; research consultations, including biostatistics, study design, and participant recruitment support; and funding opportunities and specific support for clinical trials operations.

Early Career Transitions

Justin C. McArthur, MBBS, MPH, FANA, Director, Department of Neurology; Professor of Neurology, Johns Hopkins University School of Medicine

This session will focus on the following transition points early in an academic career: 1. Seizing new opportunities to pursue a new clinical or research path; 2. How to pivot research when funding stops or the experiments crash; 3. Reformatting a mentoring team when mentors change.

Heather MacLean, Senior Director, Office of Development and Alumni Affairs, New York University Grossman School of Medicine

Philanthropy has the ability to be transformative for an institution, department, or disease area. It can encourage collaborative research, provide critical funds for supplemental clinical services, enable programmatic expansion, and enable flexibility in an ever-changing healthcare environment. But how does it all happen? We’ll explore philanthropic topics such as grateful patient fundraising, advocating for your research, and identifying and applying for foundation grant support. We’ll seek to answer questions such as: How do I identify those who might be interested in supporting my work? Are donors only interested in research? How do I find foundations interested in my area of expertise? How can I leverage philanthropy for NIH grants? What about hosting an event?..... and many more.

Rachel Kenney, PhD, Assistant Professor of Neurology and Population Health, New York University Grossman School of Medicine

This presentation will include information about the use of AI in research and writing.

Cathy, Krendel, Wiley Journal Management/ Editorial Team

This session will offer a brief general overview of do’s and don’ts when preparing a manuscript for submission to a medical journal. 
*This talk will not be specific to Annals of Neurology or Annals of Clinical and Translational Neurology.

Aaron Nelson, MD, Associate Professor, Department of Neurology; Director, Epilepsy, Bellevue Hospital Center; Director, Pediatric Neurology Residency Program, New York University School of Medicine

Networking is a learned skill--and social media is no different! Learn about the various ever-evolving platforms, when and how to best post, and how to recognize opportunities for graceful self-promotion. By the end you should be able to develop your own leadership narrative / elevator pitch, and be(come) prepared to put it into action!